Medtronic Comprehensive Income (Loss), Net of Tax, Attributable to Parent decreased by 36.1% to $1.09B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 36.2%, from $1.71B to $1.09B. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger overall financial performance and equity growth for the parent company.
This represents the total comprehensive income or loss attributable specifically to the parent company's shareholders af...
Standard financial reporting metric used by all public companies to show total equity changes.
other_comprehensive_income_net_of_tax| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04B | $1.48B | $1.64B | $1.26B | $5.00M | $394.00M | $616.00M | $1.21B | $1.24B | $950.00M | $1.43B | $1.71B | $720.00M | $1.70B | $1.09B |
| QoQ Change | — | +42.3% | +11.0% | -23.5% | -99.6% | >999% | +56.3% | +95.8% | +2.8% | -23.4% | +50.6% | +19.1% | -57.8% | +136.5% | -36.1% |
| YoY Change | — | — | — | +20.8% | -99.7% | -76.0% | -50.9% | >999% | +214.7% | +54.2% | +18.7% | +37.5% | -24.2% | +19.0% | -36.2% |